ABBVIE

ABBVIE

Displaying 10 out of 14 results

  1. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    AbbVie terminates late-stage lung cancer trial

    AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed ...
  2. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's biosimilar to AbbVie's Humira wins FDA approval

    The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the ...
  3. AbbVie

    US biopharma AbbVie to buy Botox maker Allergan for US$63b

  4. FILE PHOTO: The Allergan logo is seen in this photo illustration in Singapore

    AbbVie looks beyond Humira with US$63 billion deal for Botox-maker Allergan

    AbbVie Inc is nearing a deal to buy Botox-maker Allergan PLC for more than US$60 billion, the Wall Street Journal reported on Tuesday, citing ...
  5. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    AbbVie halts enrollment after brain cancer trial misses goal, shares fall

    AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to ...
  6. FILE PHOTO:  A trader works by the post that trades AbbVie on the floor of the New York Stock Excha

    AbbVie's Skyrizi drug to treat psoriasis wins US approval

    AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when ...
  7. New Content Item

    FDA puts partial hold on clinical trials of AbbVie's cancer drug

  8. A trader works by the post that trades AbbVie on the floor of the New York Stock Exchange

    Abbvie to record US$4 billion impairment charges on Stemcentrx assets

    Abbvie Inc on Friday said https://bit.ly/2F9iUlb it will record an estimated US$4 billion in impairment charges related to the scrapping of its ...
  9. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the N

    AbbVie, Roche combo treatment meets main goal of leukemia trial

    AbbVie Inc and Roche Holding AG said on Wednesday their immunotherapy delayed the progression of a type of blood and bone marrow cancer when used ...
  10. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the N

    Abbott, AbbVie settle US case over TriCor marketing for US$25 million

    Abbott Laboratories and AbbVie Inc will pay US$25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for them ...